Alembic Pharmaceuticals gets USFDA go-ahead for bladder drug
According to IMS December 2016 data, Darifenacin extended release tablets had an estimated market size of USD 64 million.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Pharmaceuticals